Skip to content
  • Follow Us
CarboHyde
  • Home
  • CarboHyde Cyclodextrin Masterclass XIII
  • About Us
  • Pipeline
  • CarboHyde’s Blog
  • News
  • Carbohydrate Chronicles Podcast
    • Carbohydrate Chronicles Season 2 / Ep 1 Application beyond pharma
    • Carbohydrate Chronicles Season 2 / Ep 2 Cyclodextrin in biologic formulation
    • Carbohydrate Chronicles Season 2 / Ep 3 Safety and toxicity
    • Carbohydrate Chronicles Season 2 / Ep 4 Cyclodextrin in food and nutraceuticals
    • Carbohydrate Chronicles Season 2 / Ep 5 Cyclodextrins to improve sport performance
    • Carbohydrate Chronicles Season 2 / Ep 6 Cyclodextrins in 3D printing
    • Carbohydrate Chronicles Season 2 / Ep 7 Cyclodextrin complex in the making
    • Carbohydrate Chronicles Season 2 / Ep 8 How can cyclodextrins enhance solubility?
    • Carbohydrate Chronicles Season 2 / Ep 9 Curcumin and Cyclodextrin Synergy
    • Carbohydrate Chronicles Season 2 / Ep 10 The Hidden Market Power of Cyclodextrins
  • Home
  • CarboHyde Cyclodextrin Masterclass XIII
  • About Us
  • Pipeline
  • CarboHyde’s Blog
  • News
  • Carbohydrate Chronicles Podcast
    • - Carbohydrate Chronicles Season 2 / Ep 1 Application beyond pharma
    • - Carbohydrate Chronicles Season 2 / Ep 2 Cyclodextrin in biologic formulation
    • - Carbohydrate Chronicles Season 2 / Ep 3 Safety and toxicity
    • - Carbohydrate Chronicles Season 2 / Ep 4 Cyclodextrin in food and nutraceuticals
    • - Carbohydrate Chronicles Season 2 / Ep 5 Cyclodextrins to improve sport performance
    • - Carbohydrate Chronicles Season 2 / Ep 6 Cyclodextrins in 3D printing
    • - Carbohydrate Chronicles Season 2 / Ep 7 Cyclodextrin complex in the making
    • - Carbohydrate Chronicles Season 2 / Ep 8 How can cyclodextrins enhance solubility?
    • - Carbohydrate Chronicles Season 2 / Ep 9 Curcumin and Cyclodextrin Synergy
    • - Carbohydrate Chronicles Season 2 / Ep 10 The Hidden Market Power of Cyclodextrins
CarboHyde
  • Home
  • CarboHyde Cyclodextrin Masterclass XIII
  • About Us
  • Pipeline
  • CarboHyde’s Blog
  • News
  • Carbohydrate Chronicles Podcast
    • Carbohydrate Chronicles Season 2 / Ep 1 Application beyond pharma
    • Carbohydrate Chronicles Season 2 / Ep 2 Cyclodextrin in biologic formulation
    • Carbohydrate Chronicles Season 2 / Ep 3 Safety and toxicity
    • Carbohydrate Chronicles Season 2 / Ep 4 Cyclodextrin in food and nutraceuticals
    • Carbohydrate Chronicles Season 2 / Ep 5 Cyclodextrins to improve sport performance
    • Carbohydrate Chronicles Season 2 / Ep 6 Cyclodextrins in 3D printing
    • Carbohydrate Chronicles Season 2 / Ep 7 Cyclodextrin complex in the making
    • Carbohydrate Chronicles Season 2 / Ep 8 How can cyclodextrins enhance solubility?
    • Carbohydrate Chronicles Season 2 / Ep 9 Curcumin and Cyclodextrin Synergy
    • Carbohydrate Chronicles Season 2 / Ep 10 The Hidden Market Power of Cyclodextrins

Cyclo Therapeutics Announces Publication of Phase 1 Data for Trappsol® Cyclo™ for the Treatment of Niemann-Pick Disease Type C1 (NPC1)

Nov 7, 2022Tamas Sohajdadrug developmentcholesterol, clinical trial, cyclodextrin, rare disease

Cyclo Therapeutics, Inc. (Caroline Hastings, Benny Liu, Bryan Hurst, Gerald Cox and Sharon Hrynkow) Announces Publication of Phase 1 Data for Trappsol® Cyclo™ for the Treatment of Niemann-Pick Disease Type C1 (NPC1)

Artikle: https://www.sciencedirect.com/science/article/pii/S109671922200419X

Cyclo Therapeutics Announces Publication of Phase 1 Data for Trappsol® Cyclo™ for the Treatment of Niemann-Pick Disease Type C1 (NPC1)

Prev
Next
Developed by Shuttle Themes. Powered by WordPress.
  • Contact Us
  • LinkedIn
  • Twitter
  • Privacy Policy